Biomerieux SA

EYWN-FF:Frankfurt Stock Exchange
RT Quote | Exchange | EUR
Last | 10:17 AM CET
131.30quote price arrow up+4.10 (+3.22%)
Volume
112
52 week range
114.20 - 131.30

...

Loading . . .

KEY STATS

  • Open128.50
  • Day High131.30
  • Day Low128.50
  • Prev Close127.20
  • 52 Week High131.30
  • 52 Week High Date01/27/21
  • 52 Week Low114.20
  • 52 Week Low Date01/12/21
  • Market Cap17,795.12M
  • Shares Out118.35M
  • 10 Day Average Volume199.18
  • Dividend0.19
  • Dividend Yield0.14%
  • Beta
  • 1 Year % Change46.95

RATIOS/PROFITABILITY

  • EPS (TTM)2.58
  • P/E (TTM)50.89
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date07/14/2020
  • Div Amount0.19
  • Split Date-
  • Split Factor-

Latest Biomerieux SA News

There is no recent news for this security.

Latest EYWN-FF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the...
Alexandre Merieux
Chairman
Pierre Boulud
Chief Operating Officer
Guillaume Bouhours
Chief Financial Officer
Nicolas Cartier
Executive Vice President
Mark Miller
Executive Vice President
Address
376 chemin de l'Orme
Marcy-l Etoile
69280
France